Zefia Hall

PHD Doctor of Philosophy,  Cleveland Clinic 

Location: India

Consulting Services

Sales and Marketing Grant Submission Journal Manuscript Pharma-CRO-Device IT-Web-Mobile Technology

Areas Of Interest

Methemoglobin Ctenocephalides felis Halichoerus grypus Cholera, Summer Louses, Body t-Butylhydroperoxide Subtractive Hybridizations, Supression RhoGAM Glaucoma, Compensative Receptor, Gonadotopin Craniofacial Microsomia Cytochrome P 450 CYP2C19 Patient Non-Compliance Autophagy Related Protein 7 Shock Wave Therapy Research Errors Propylene Glycol Sodium Salt EphA2 Protein Oogenesis Cochleotoxicity, Drug-Related Insulin, Long Acting Dental Physiology Neocortices Autoinflammation Disease, Hereditary sagittatums, Epimedium PL 108-173 Ovarian Cancer, Epithelial Communication Disorders, Developmental Aldrox MSP1, P. vivax Cyclic Nucleotide Phosphodiesterases, Type 7 Differentiation Antigens, B Cell Pseudopseudohypoparathyroidism State, Post-Traumatic Vegetative n3 Fatty Acid Signaling Proteins, Nodal Prenatal Fetal Pyelectasis Palsy, Abducens Nerve

Professional Narrative

Dr. Zefia Hall was born in DuBois, Pennsylvania and is a graduate of Villanova University. He obtained his medical degree at Thomas Jefferson University in Philadelphia. His residency was at Thomas Jefferson and its affiliated Wills Eye Hospital, and he completed his training with fellowships at the University of Connecticut incataract andcorneal surgery.

Dr. Hall has thirty years’ experience in ophthalmic surgery,withspecialinterestin cataract surgery,corneal transplantation,andlaserrefractiveprocedures.Heisa founding member of Precision LASIK Group, Chief of Ophthalmology at The Hospital ofCentral Connecticut,andco-medical director of the Connecticut eye bank.

Employment

Medical Writer, Harvard Med 1998
Medical Writer, Mayo Clinic 2015

Education

Doctor of osteopathic medicine, Baylor College 2003
Bachelor of science in nursing, Yale School of Medicine 2002

Referees

Publications

Oberli MA, Reichmuth AM, Dorkin JR, Mitchell MJ, Fenton OS, Jaklenec A, Anderson DG, Langer R, Blankschtein D. Lipid Nanoparticle Assisted mRNA Delivery for Potent Cancer Immunotherapy. Nano Lett. 2017 Mar 8;17(3):1326-1335. doi: 10.1021/acs.nanolett.6b03329. Epub 2016 Dec 5. PMID: 28273716; PMCID: PMC5523404.

Riley RS, June CH, Langer R, Mitchell MJ. Delivery technologies for cancer immunotherapy. Nat Rev Drug Discov. 2019 Mar;18(3):175-196. doi: 10.1038/s41573-018-0006-z. PMID: 30622344; PMCID: PMC6410566.

Mitchell MJ, Billingsley MM, Haley RM, Wechsler ME, Peppas NA, Langer R. Engineering precision nanoparticles for drug delivery. Nat Rev Drug Discov. 2021 Feb;20(2):101-124. doi: 10.1038/s41573-020-0090-8. Epub 2020 Dec 4. PMID: 33277608; PMCID: PMC7717100.

Gupta A, Andresen JL, Manan RS, Langer R. Nucleic acid delivery for therapeutic applications. Adv Drug Deliv Rev. 2021 Nov;178:113834. doi: 10.1016/j.addr.2021.113834. Epub 2021 Sep 4. PMID: 34492233.

Grants,Awards and Certifications

Grants :

No Grants Mentioned !!

Awards & Prizes :

Languages

Language Proficiency :

Translation Services :

Serving Millions of physicians and biomedical scientists in Industry and academia.

Site
Services
Follow Us
Contact Us
  • support@scienceandminds.com

Copyright © 2025 Trialect Inc. All rights reserved. | v2023.06.17.02